Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07SOJ
|
|||
| Former ID |
DIB004245
|
|||
| Drug Name |
Adenovirus/Semliki Forest virus hybrid vector delivered IL-12 immunotherapy
|
|||
| Synonyms |
Adenovirus/Semliki Forest virus hybrid vector delivered IL-12 immunotherapy (hepatitis B virus infection, hepatocellular carcinoma); Adenovirus/Semliki Forest virus hybrid vector delivered IL-12 immunotherapy (hepatocellular carcinoma), Digna Biotech; Adenovirus/Semliki Forest virus hybrid vector delivered IL-12 immunotherapy (hepatitis B virus infection, hepatocellular carcinoma), Digna Biotech
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Investigative | [1] | |
| Company |
Digna Biotech SL
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.